chr1:22710839:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr1:23,037,332-23,247,993 |
hg38 | chr1:22,710,839-22,921,500 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Transitional Cell | In summary loss of EphB2 and gain of EphB4 expression represents an inflection p... | BeFree | 25148033 | Detail |
<0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
<0.001 | Developmental Disabilities | NA | BeFree | Detail | |
<0.001 | chondrosarcoma | NA | BeFree | Detail | |
<0.001 | chordoma | NA | BeFree | Detail | |
<0.001 | choriocarcinoma | CXCL12-CXCR7 signaling activates ERK and Akt pathways in human choriocarcinoma c... | BeFree | 24450273 | Detail |
<0.001 | colitis | NA | BeFree | Detail | |
<0.001 | ulcerative colitis | NA | BeFree | Detail | |
<0.001 | Colonic Neoplasms | NA | BeFree | Detail | |
0.010 | colorectal carcinoma | Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in c... | BeFree | 25051350 | Detail |
0.010 | colorectal carcinoma | Taken together, the present study demonstrated that BK increases IL-6 production... | BeFree | 25109623 | Detail |
0.010 | colorectal carcinoma | In conclusion, PXN promotes Bcl-2 phosphorylation at Serine 87 via PXN-mediated ... | BeFree | 25826088 | Detail |
0.013 | Colorectal Neoplasms | TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphory... | BeFree,LHGDN | 25239454 | Detail |
0.013 | Colorectal Neoplasms | Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-me... | BeFree,LHGDN | 25826088 | Detail |
<0.001 | Crohn Disease | NA | BeFree | Detail | |
<0.001 | adenoid cystic carcinoma | NA | BeFree | Detail | |
<0.001 | scleroderma | NA | BeFree | Detail | |
<0.001 | Diabetic Angiopathies | Our results indicate that an MKP-3 pathway might regulate ERK dephosphorylation ... | BeFree | 25014566 | Detail |
<0.001 | Dwarfism | NA | BeFree | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
<0.001 | endometriosis | Up-regulation of Bcl-2 by CD147 Through ERK Activation Results in Abnormal Cell ... | BeFree | 25996258 | Detail |
0.121 | Ependymoma | EphB2 activation is required for ependymoma development as well as inhibits diff... | BeFree,CTD_human | 25801123 | Detail |
<0.001 | epidermodysplasia verruciformis | NA | BeFree | Detail | |
<0.001 | epilepsy | NA | BeFree | Detail | |
<0.001 | Fanconi anemia | NA | BeFree | Detail | |
0.003 | glioblastoma | Application of a specific extracellular-related kinase 1/2 (ERK1/2) inhibitor, b... | BeFree | 25213694 | Detail |
0.008 | Glioma | Here we propose that the blinding of cell-cell contact sensing in gliomas is cau... | BeFree,LHGDN | 24858041 | Detail |
0.008 | Glioma | Furthermore, AND did not induce apoptosis or activate ERK and p53 in primary cul... | BeFree,LHGDN | 25162007 | Detail |
0.008 | Glioma | Taken together, our findings showed that HDAC3 contributed to VM in gliomas, pos... | BeFree,LHGDN | 25940092 | Detail |
<0.001 | Severe Dengue | Syk and ERK may serve as new therapeutic targets for interfering with ADE-induce... | BeFree | 26032420 | Detail |
<0.001 | hepatitis B | NA | BeFree | Detail | |
0.002 | HIV Infections | The results of BNDF research show that neurotrophins regulate miRNAs in at least... | BeFree | 25544363 | Detail |
<0.001 | hyperglycemia | These results indicate that high AR expression in the context of hyperglycemia a... | BeFree | 25541468 | Detail |
<0.001 | hyperinsulinism | Irisin treatment significantly increased insulin-like growth factor 1 and decrea... | BeFree | 24614098 | Detail |
<0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
<0.001 | Immune System Diseases | NA | BeFree | Detail | |
0.001 | influenza | NA | BeFree | Detail | |
<0.001 | Kidney Neoplasm | NA | BeFree | Detail | |
<0.001 | Fibroid Tumor | NA | BeFree | Detail | |
<0.001 | leukemia | NA | BeFree | Detail | |
0.002 | chronic lymphocytic leukemia | We also found that blocking ET(A)R via BQ-123 interferes with ERK phosphorylatio... | BeFree | 24901342 | Detail |
0.002 | chronic lymphocytic leukemia | BRAF inhibitor-associated ERK activation drives development of chronic lymphocyt... | BeFree | 25329694 | Detail |
0.001 | hairy cell leukemia | NA | BeFree | Detail | |
0.002 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | Leukemia, Myelomonocytic, Chronic | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | Liver neoplasms | NA | BeFree | Detail | |
<0.001 | Lung Neoplasms | At the molecular level, reduced activation of ERK MAPK, but not Akt, was observe... | BeFree | 24727895 | Detail |
0.001 | Lupus Vulgaris | NA | BeFree | Detail | |
0.001 | Lupus Erythematosus, Discoid | NA | BeFree | Detail | |
0.002 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
<0.001 | Lyme disease | NA | BeFree | Detail | |
<0.001 | lymphoma | We discovered that YC-1 induces apoptosis and inhibits tumour growth of breast c... | BeFree | 24697523 | Detail |
<0.001 | lymphoma | Mechanistically, SHP2/ERK inhibition impedes c-Myc transcriptional activity, whi... | BeFree | 25193962 | Detail |
<0.001 | Lymphoma, Non-Hodgkin | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of stomach | Deactivation of phosphorylation of ERK protein is one of the mechanisms of soraf... | BeFree | 25136776 | Detail |
0.007 | Malignant neoplasm of stomach | These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that ... | BeFree | 25674211 | Detail |
0.007 | Malignant neoplasm of stomach | WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the e... | BeFree | 26291058 | Detail |
<0.001 | medulloblastoma | NA | BeFree | Detail | |
<0.001 | Mesothelioma | Mesothelioma tumors are locally invasive and our results clearly suggest that ac... | BeFree | 25557874 | Detail |
0.003 | multiple myeloma | In summary, our results suggest that quercetin suppresses the proliferation of M... | BeFree | 24397597 | Detail |
0.013 | Neoplasm Metastasis | Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its ... | BeFree,LHGDN | 24722280 | Detail |
0.013 | Neoplasm Metastasis | The oncogene ABL1 was a direct miR-3127-5p target, and miR-3127-5p regulated the... | BeFree,LHGDN | 25284075 | Detail |
0.013 | Neoplasm Metastasis | In conclusion, these findings demonstrate that EMT can be regulated by the CCL19... | BeFree,LHGDN | 25359618 | Detail |
0.013 | Neoplasm Metastasis | In conclusion, this study suggested that EMT process can be triggered by the BMP... | BeFree,LHGDN | 25448881 | Detail |
0.013 | Neoplasm Metastasis | We also show that mice that have tumors with intrinsically high levels of active... | BeFree,LHGDN | 25853295 | Detail |
0.013 | Neoplasm Metastasis | WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the e... | BeFree,LHGDN | 26291058 | Detail |
0.003 | neuroblastoma | A cell-based assay was developed using natively expressed ORL-1 receptors on mou... | BeFree | 25677767 | Detail |
0.003 | neuroblastoma | Mechanistically treatment of NBs with small molecule inhibitors of EGFR (erlotin... | BeFree | 25756510 | Detail |
0.003 | neuroblastoma | Furthermore, the amount of phosphorylation of the kinase ERK and neurite outgrow... | BeFree | 25921289 | Detail |
<0.001 | neurofibroma | NA | BeFree | Detail | |
<0.001 | neurofibromatosis 1 | Moving beyond BRAFV600 targeting, a number of other molecular subsets--such as m... | BeFree | 25993155 | Detail |
0.003 | Noonan syndrome | NA | BeFree | Detail | |
<0.001 | obesity | Current data exclude a major function of these syntrophins in ABCA1 activity and... | BeFree | 25625330 | Detail |
<0.001 | Opioid withdrawal | Our data suggest that H2S prevents the development of opioid withdrawal-induced ... | BeFree | 24824948 | Detail |
<0.001 | Degenerative polyarthritis | To investigate the involvement of these pathways in the Naproxen-induced COL10A1... | BeFree | 25091567 | Detail |
0.002 | osteosarcoma | Taken together, data show CTGF elevating MMPs expression and subsequently promot... | BeFree | 25003330 | Detail |
0.002 | osteosarcoma | Taken together, our data suggest that miR-143 inhibits EGFR signaling through it... | BeFree | 25227664 | Detail |
0.005 | ovarian carcinoma | These regulatory effects of EC on ovarian cancer cell proliferation, migration a... | BeFree | 24892518 | Detail |
0.005 | ovarian carcinoma | MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth fa... | BeFree | 25176450 | Detail |
0.005 | ovarian carcinoma | In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B... | BeFree | 25375375 | Detail |
0.005 | ovarian carcinoma | We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is onco... | BeFree | 25965947 | Detail |
<0.001 | Pancreatic Neoplasm | NA | BeFree | Detail | |
0.003 | Parkinson disease | ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: ... | BeFree,GAD | 24768991 | Detail |
<0.001 | periodontitis | NA | BeFree | Detail | |
<0.001 | Peripheral neuropathy | NA | BeFree | Detail | |
<0.001 | pheochromocytoma | NA | BeFree | Detail | |
<0.001 | pituitary adenoma | NA | BeFree | Detail | |
<0.001 | Pituitary Neoplasms | NA | BeFree | Detail | |
<0.001 | polycythemia vera | NA | BeFree | Detail | |
<0.001 | Adenomatous Polyposis Coli | NA | BeFree | Detail | |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
0.003 | Prostatic Neoplasms | NA | LHGDN | Detail | |
<0.001 | pseudomyxoma peritonei | We tested RDEA119, a specific MEK1/2 (MAPK extracellular signal-regulated kinase... | BeFree | 25890193 | Detail |
<0.001 | pyruvate carboxylase deficiency disease | NA | BeFree | Detail | |
<0.001 | Reoviridae Infections | NA | BeFree | Detail | |
<0.001 | retinoblastoma | MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactiv... | BeFree | 25070358 | Detail |
0.002 | rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | Kaposi sarcoma | Taken together, our data suggest that miR99a inhibits MMP7 and MMP13 through PI3... | BeFree | 25234715 | Detail |
<0.001 | schizophrenia | NA | BeFree | Detail | |
<0.001 | systemic scleroderma | NA | BeFree | Detail | |
<0.001 | Seizures | NA | BeFree | Detail | |
<0.001 | pheochromocytoma | When expressed in rat pheochromocytoma cell line cells, the R151C, R160W and D29... | BeFree | 19755124 | Detail |
0.006 | Stomach Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | substance dependence | NA | BeFree | Detail | |
<0.001 | synovial sarcoma | NA | BeFree | Detail | |
<0.001 | thyroiditis | NA | BeFree | Detail | |
<0.001 | tuberous sclerosis | NA | BeFree | Detail | |
<0.001 | Unipolar Depression | Eighty percent of these genes were functionally associated with a key stress res... | BeFree | 25734512 | Detail |
<0.001 | Uterine Fibroids | NA | BeFree | Detail | |
0.001 | Virus Diseases | NA | BeFree | Detail | |
<0.001 | yellow fever | MEK/ERK activation plays a decisive role in yellow fever virus replication: impl... | BeFree | 25241249 | Detail |
<0.001 | AIDS-Associated Nephropathy | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | Lupalbigenin treatment significantly down-regulated survival proteins, including... | BeFree | 25964563 | Detail |
<0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
<0.001 | Lymphoma, T-Cell, Cutaneous | NA | BeFree | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | Neurofibrillary degeneration (morphologic abnormality) | NA | BeFree | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Cutaneous Melanoma | NA | BeFree | Detail | |
<0.001 | Dry skin | NA | BeFree | Detail | |
0.002 | Adenocarcinoma of lung (disorder) | LATS2 mRNA level was found to be a significant independent predictor for surviva... | BeFree | 24976335 | Detail |
0.002 | Adenocarcinoma of lung (disorder) | Genetic alterations affecting the MAPK/ERK pathway are common in lung adenocarci... | BeFree | 25351745 | Detail |
0.002 | Adenocarcinoma of lung (disorder) | To elucidate how EGFR signaling is linked to metabolic activity, we investigated... | BeFree | 26023239 | Detail |
<0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of mouth | A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and... | BeFree | 25091805 | Detail |
<0.001 | Malignant neoplasm of gallbladder | ARB blocked A2-induced GBC cell growth and activated ERK. | BeFree | 25663464 | Detail |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of bone | NA | BeFree | Detail | |
<0.001 | Dermatitis, Allergic Contact | NA | BeFree | Detail | |
<0.001 | Sotos' syndrome | NA | BeFree | Detail | |
0.003 | Tumor Progression | Furthermore, while p53R2, a p53-inducible peptide involved in the synthesis of d... | BeFree | 25086499 | Detail |
<0.001 | Dysplastic Nevus | NA | BeFree | Detail | |
<0.001 | alveolar rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | Rhabdomyosarcoma, Embryonal | NA | BeFree | Detail | |
<0.001 | teratocarcinoma | NA | BeFree | Detail | |
<0.001 | adrenocortical carcinoma | NA | BeFree | Detail | |
<0.001 | mucoepidermoid carcinoma | NA | BeFree | Detail | |
<0.001 | cholangiocarcinoma | NA | BeFree | Detail | |
<0.001 | Cystadenocarcinoma, Serous | NA | BeFree | Detail | |
<0.001 | Nerve Sheath Tumors | NA | BeFree | Detail | |
<0.001 | Neuroendocrine Tumors | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Lip and oral cavity carcinoma | A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and... | BeFree | 25091805 | Detail |
<0.001 | Intestinal carcinoma | Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large int... | BeFree | 25253956 | Detail |
<0.001 | Memory impairment | NA | BeFree | Detail | |
<0.001 | gallbladder carcinoma | ARB blocked A2-induced GBC cell growth and activated ERK. | BeFree | 25663464 | Detail |
0.004 | pancreatic carcinoma | Further analysis showed that Cyr61 seemed to activate phosphatidylinositol 3-kin... | BeFree | 25104090 | Detail |
0.004 | pancreatic carcinoma | ERK pathway knockdown suppressed pancreatic cancer cell proliferation, invasion,... | BeFree | 25646808 | Detail |
0.004 | pancreatic carcinoma | We propose that dual PI3K/mTOR inhibitors suppress a novel negative feedback loo... | BeFree | 25673820 | Detail |
0.004 | pancreatic carcinoma | ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreat... | BeFree | 25753158 | Detail |
<0.001 | Gastrointestinal Stromal Tumors | Analysis of western blotting data showed that total protein isoforms of Raf, MEK... | BeFree | 24970355 | Detail |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma of thyroid | Our investigation of the molecular mechanisms underlying these effects revealed ... | BeFree | 25435367 | Detail |
0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of lung | The expression of tumour suppressor genes was reduced in tumours from current ve... | BeFree | 24727895 | Detail |
0.004 | Malignant neoplasm of lung | The results indicated that Sorcin may be used as a potential therapeutic target ... | BeFree | 25394367 | Detail |
0.004 | Malignant neoplasm of lung | Here, we reported that the AKT inhibitor perifosine and the MEK\ERK inhibitor ME... | BeFree | 25697899 | Detail |
<0.001 | Neoplasm, Residual | NA | BeFree | Detail | |
<0.001 | Congenital absence of liver | NA | BeFree | Detail | |
<0.001 | Isovaleryl-CoA dehydrogenase deficiency | Guanine nucleotide binding protein alpha13 (GNA13) and protein tyrosine phosphat... | BeFree | 25193986 | Detail |
<0.001 | Myelokathexis | NA | BeFree | Detail | |
<0.001 | Virchow's node (disorder) | Genome-wide analyses have identified four major signaling nodes that are most fr... | BeFree | 25070358 | Detail |
<0.001 | Malignant neoplasm of colon stage IV | NA | BeFree | Detail | |
<0.001 | Medulloblastoma, Childhood | NA | BeFree | Detail | |
<0.001 | Metastatic Renal Cell Cancer | C5aR is frequently expressed in metastatic renal cell carcinoma and plays a cruc... | BeFree | 25682807 | Detail |
0.001 | Metastatic melanoma | In this article, Paul B. Chapman, MD, Memorial Sloan Kettering Cancer Center, su... | BeFree | 24857055 | Detail |
0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells. | BeFree | 25747387 | Detail |
<0.001 | Squamous cell carcinoma of esophagus | Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21... | BeFree | 25175641 | Detail |
<0.001 | Squamous cell carcinoma of esophagus | Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pat... | BeFree | 25620088 | Detail |
<0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
<0.001 | Transitional cell carcinoma of bladder | The differential expression of EphB2 and EphB4 receptor kinases in normal bladde... | BeFree | 25148033 | Detail |
<0.001 | Solid tumour | In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B... | BeFree | 25375375 | Detail |
<0.001 | Oligodendroglioma, Childhood | Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediat... | BeFree | 25794445 | Detail |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | cervix carcinoma | NA | BeFree | Detail | |
<0.001 | High-Grade Squamous Intraepithelial Lesions | NA | BeFree | Detail | |
<0.001 | Hyperplastic Polyp | NA | BeFree | Detail | |
<0.001 | Multiple polyps | NA | BeFree | Detail | |
0.001 | pilocytic astrocytoma | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of liver | Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells. | BeFree | 25747387 | Detail |
<0.001 | malignant mesothelioma | Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 ... | BeFree | 25557874 | Detail |
<0.001 | Malignant melanoma of choroid | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of pancreas | ERK pathway knockdown suppressed pancreatic cancer cell proliferation, invasion,... | BeFree | 25646808 | Detail |
0.003 | Malignant neoplasm of pancreas | We propose that dual PI3K/mTOR inhibitors suppress a novel negative feedback loo... | BeFree | 25673820 | Detail |
0.003 | Malignant neoplasm of pancreas | ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreat... | BeFree | 25753158 | Detail |
<0.001 | juvenile myelomonocytic leukemia | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | Combined CagA expression, p-SHP-2 expression, and p-ERK expression showed an inc... | BeFree | 25871616 | Detail |
<0.001 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.132 | Malignant neoplasm of prostate | MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactiv... | BeFree,GAD,UNIPROT | 25070358 | Detail |
0.132 | Malignant neoplasm of prostate | Chloride intracellular channel 1 regulates prostate cancer cell proliferation an... | BeFree,GAD,UNIPROT | 25279971 | Detail |
0.132 | Malignant neoplasm of prostate | Finally, the results demonstrated that AQP3 upregulated matrix metalloproteinase... | BeFree,GAD,UNIPROT | 25515250 | Detail |
<0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
<0.001 | Lymphatic Abnormalities | NA | BeFree | Detail | |
0.001 | lupus erythematosus | NA | BeFree | Detail | |
0.002 | endometrial carcinoma | Functional bioinformatics analysis identified as downstream targets multiple sig... | BeFree | 25686835 | Detail |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Recurrent tumor | NA | BeFree | Detail | |
<0.001 | Neurodegenerative Disorders | This research highlights new bioactivities for gracilins, such as BACE1 and ERK ... | BeFree | 25724081 | Detail |
0.002 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of skin | CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinom... | BeFree | 25256412 | Detail |
<0.001 | Squamous cell carcinoma of skin | EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. | BeFree | 25789706 | Detail |
<0.001 | Malignant glioma | NA | BeFree | Detail | |
0.002 | Osteosarcoma of bone | Taken together, data show CTGF elevating MMPs expression and subsequently promot... | BeFree | 25003330 | Detail |
0.002 | Osteosarcoma of bone | Taken together, our data suggest that miR-143 inhibits EGFR signaling through it... | BeFree | 25227664 | Detail |
<0.001 | Costello syndrome (disorder) | NA | BeFree | Detail | |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
0.009 | prostate carcinoma | MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactiv... | BeFree | 25070358 | Detail |
0.009 | prostate carcinoma | Chloride intracellular channel 1 regulates prostate cancer cell proliferation an... | BeFree | 25279971 | Detail |
0.009 | prostate carcinoma | Finally, the results demonstrated that AQP3 upregulated matrix metalloproteinase... | BeFree | 25515250 | Detail |
<0.001 | Hashimoto Disease | Furthermore, BAG3 knockdown increased the HT-induced phosphorylation of ERK afte... | BeFree | 25471019 | Detail |
0.002 | Epithelial ovarian cancer | In conclusion, CrkL protein is required for TGF-β signal pathways through AKT an... | BeFree | 25307974 | Detail |
0.002 | Epithelial ovarian cancer | CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathway... | BeFree | 25359618 | Detail |
<0.001 | Refractory cancer | By far, the most common clinical resistance mechanism involves reactivation of t... | BeFree | 25320010 | Detail |
0.012 | breast carcinoma | As the MAPK pathway is an important target for treating triple-negative breast c... | BeFree | 25073112 | Detail |
0.012 | breast carcinoma | Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in brea... | BeFree | 25127034 | Detail |
0.012 | breast carcinoma | Verification of EPHB2 regulation by TGF-β3 and p53 was performed on breast cance... | BeFree | 25257729 | Detail |
0.012 | breast carcinoma | Computational design, chemical synthesis, and biological evaluation of a novel E... | BeFree | 25742792 | Detail |
0.012 | breast carcinoma | Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced act... | BeFree | 26006730 | Detail |
0.004 | Carcinoma of lung | The expression of tumour suppressor genes was reduced in tumours from current ve... | BeFree | 24727895 | Detail |
0.004 | Carcinoma of lung | The results indicated that Sorcin may be used as a potential therapeutic target ... | BeFree | 25394367 | Detail |
0.004 | Carcinoma of lung | Here, we reported that the AKT inhibitor perifosine and the MEK\ERK inhibitor ME... | BeFree | 25697899 | Detail |
0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
0.003 | colon carcinoma | Activation of Rac1-ERK pathway and consequent upregulation of MMP-7 production m... | BeFree | 25136657 | Detail |
0.003 | colon carcinoma | Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway gene... | BeFree | 25889965 | Detail |
0.007 | stomach carcinoma | These data suggest that EGF-induced activation of MMP7 and MMP13 in GC is throug... | BeFree | 25085584 | Detail |
0.007 | stomach carcinoma | Deactivation of phosphorylation of ERK protein is one of the mechanisms of soraf... | BeFree | 25136776 | Detail |
0.007 | stomach carcinoma | These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that ... | BeFree | 25674211 | Detail |
0.007 | stomach carcinoma | WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the e... | BeFree | 26291058 | Detail |
<0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
0.003 | Central neuroblastoma | A cell-based assay was developed using natively expressed ORL-1 receptors on mou... | BeFree | 25677767 | Detail |
0.003 | Central neuroblastoma | Mechanistically treatment of NBs with small molecule inhibitors of EGFR (erlotin... | BeFree | 25756510 | Detail |
0.003 | Central neuroblastoma | Furthermore, the amount of phosphorylation of the kinase ERK and neurite outgrow... | BeFree | 25921289 | Detail |
<0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
<0.001 | malignant peripheral nerve sheath tumor | NA | BeFree | Detail | |
<0.001 | Kabuki make-up syndrome | RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome. | BeFree | 26280580 | Detail |
<0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
<0.001 | premalignant lesion | Tumor cell-specific overexpression of EphB2 was detected in human cSCCs and in c... | BeFree | 25789706 | Detail |
0.002 | Rhabdoid Tumor of the Kidney | NA | BeFree | Detail | |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
<0.001 | Erdheim-Chester disease | NA | BeFree | Detail | |
<0.001 | ovarian neoplasm | NA | BeFree | Detail | |
<0.001 | Ischemic stroke | NA | BeFree | Detail | |
<0.001 | Primary infection NOS | NA | BeFree | Detail | |
<0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of ovary | These regulatory effects of EC on ovarian cancer cell proliferation, migration a... | BeFree | 24892518 | Detail |
0.004 | Malignant neoplasm of ovary | MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth fa... | BeFree | 25176450 | Detail |
0.004 | Malignant neoplasm of ovary | In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B... | BeFree | 25375375 | Detail |
0.004 | Malignant neoplasm of ovary | We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is onco... | BeFree | 25965947 | Detail |
<0.001 | Squamous cell carcinoma of the head and neck | One potential therapeutic target for HNSCC is the RAS/RAF/MEK/ERK cascade, which... | BeFree | 26053277 | Detail |
<0.001 | sarcoma | NA | BeFree | Detail | |
<0.001 | Traditional Serrated Adenoma | NA | BeFree | Detail | |
<0.001 | major depressive disorder | Eighty percent of these genes were functionally associated with a key stress res... | BeFree | 25734512 | Detail |
<0.001 | Cardio-facio-cutaneous syndrome | These results suggest that our new Braf knockin mice recapitulate major features... | BeFree | 25035421 | Detail |
<0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
<0.001 | Classical Hodgkin's Lymphoma | Moreover, several signal transduction pathways that are critical for the prolife... | BeFree | 25953622 | Detail |
<0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
0.001 | Mammary Neoplasms | The data suggest that ERK activation by Nodal signaling regulates c-myc and p27 ... | BeFree | 25073112 | Detail |
0.001 | Mammary Neoplasms | Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasio... | BeFree | 25656647 | Detail |
<0.001 | drug dependence | NA | BeFree | Detail | |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | Although it had relatively short half-life in serum, it was shown to be highly s... | BeFree | 25438047 | Detail |
0.012 | colorectal cancer | Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in c... | BeFree,GAD | 25051350 | Detail |
0.012 | colorectal cancer | Taken together, the present study demonstrated that BK increases IL-6 production... | BeFree,GAD | 25109623 | Detail |
0.012 | colorectal cancer | In conclusion, PXN promotes Bcl-2 phosphorylation at Serine 87 via PXN-mediated ... | BeFree,GAD | 25826088 | Detail |
<0.001 | androgen independent prostate cancer | NA | BeFree | Detail | |
<0.001 | Invasive Skin Melanoma | NA | BeFree | Detail | |
0.001 | uterine corpus cancer | Functional bioinformatics analysis identified as downstream targets multiple sig... | BeFree | 25686835 | Detail |
<0.001 | Parvovirus B19 (disease) | NA | BeFree | Detail | |
<0.001 | Philadelphia chromosome-positive acute lymphoblastic leukemia | We have also shown that metformin activates the ERK pathway in Ph+ALL cells, SUP... | BeFree | 26186064 | Detail |
0.005 | liver carcinoma | Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK thro... | BeFree | 25013376 | Detail |
0.005 | liver carcinoma | The CXCR7-ERK-HNF4α cascade represents a new target for the differentiation ther... | BeFree | 25242412 | Detail |
0.005 | liver carcinoma | These results suggest that SIRT6 is required for TGF-β1/H2O2/HOCl to enhance the... | BeFree | 25683165 | Detail |
0.005 | liver carcinoma | Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma developmen... | BeFree | 25823821 | Detail |
<0.001 | Triple-negative breast carcinoma | Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway pot... | BeFree | 25527500 | Detail |
<0.001 | Autosomal dominant focal segmental glomerulosclerosis | NA | BeFree | Detail | |
0.120 | Prostate cancer, familial | NA | BeFree,ORPHANET | Detail | |
<0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
<0.001 | Central Nervous System Sensitization | NA | BeFree | Detail | |
<0.001 | Pulmonary arterial hypertension | NA | BeFree | Detail | |
<0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
<0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
<0.001 | Serrated adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Triple Negative Breast Neoplasms | In aggressive, triple-negative, basal-like breast cancers, most tumors display i... | BeFree | 25073112 | Detail |
<0.001 | Triple Negative Breast Neoplasms | In the present study we discerned the molecular mechanisms of potential interact... | BeFree | 25527500 | Detail |
<0.001 | Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia | NA | BeFree | Detail | |
<0.001 | achondroplasia | NA | BeFree | Detail | |
0.002 | adenocarcinoma | The small interfering RNA (siRNA) was used to suppress CrkL in serous papillary ... | BeFree | 25307974 | Detail |
0.002 | adenoma | NA | BeFree | Detail | |
<0.001 | Alzheimer's disease | This research highlights new bioactivities for gracilins, such as BACE1 and ERK ... | BeFree | 25724081 | Detail |
<0.001 | Anaplasia | NA | BeFree | Detail | |
<0.001 | anthrax disease | NA | BeFree | Detail | |
<0.001 | arteriosclerosis | NA | BeFree | Detail | |
<0.001 | arthritis | NA | BeFree | Detail | |
0.002 | rheumatoid arthritis | (D) PGC-1β mediated NF-κB transcription in RA-FLS, but did not affect ERK and p3... | BeFree | 25367151 | Detail |
0.002 | rheumatoid arthritis | Sprouty2 suppresses the inflammatory responses in rheumatoid arthritis fibroblas... | BeFree | 26265114 | Detail |
0.001 | asthma | NA | BeFree | Detail | |
0.001 | Astrocytoma | NA | BeFree | Detail | |
<0.001 | atherosclerosis | NA | BeFree | Detail | |
<0.001 | autistic disorder | The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor ... | BeFree | 25698753 | Detail |
<0.001 | Mental disorders | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
<0.001 | Brain Neoplasms | The naturally secreted and O-GlcNAcylated MIF binds to EGFR, thereby inhibiting ... | BeFree | 26280537 | Detail |
0.012 | Malignant neoplasm of breast | Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in brea... | BeFree | 25127034 | Detail |
0.012 | Malignant neoplasm of breast | Verification of EPHB2 regulation by TGF-β3 and p53 was performed on breast cance... | BeFree | 25257729 | Detail |
0.012 | Malignant neoplasm of breast | Computational design, chemical synthesis, and biological evaluation of a novel E... | BeFree | 25742792 | Detail |
0.012 | Malignant neoplasm of breast | Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced act... | BeFree | 26006730 | Detail |
0.003 | Malignant tumor of colon | Activation of Rac1-ERK pathway and consequent upregulation of MMP-7 production m... | BeFree | 25136657 | Detail |
0.003 | Malignant tumor of colon | Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway gene... | BeFree | 25889965 | Detail |
0.001 | Malignant neoplasm of endometrium | Functional bioinformatics analysis identified as downstream targets multiple sig... | BeFree | 25686835 | Detail |
<0.001 | Malignant neoplasm of skin | These findings provide mechanistic evidence for the role of EphB2 in the early p... | BeFree | 25789706 | Detail |
0.002 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
<0.001 | Bronchioloalveolar Adenocarcinoma | NA | BeFree | Detail | |
<0.001 | mucinous adenocarcinoma | NA | BeFree | Detail | |
0.005 | Non-small cell lung carcinoma | Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contrib... | BeFree | 25284075 | Detail |
0.005 | Non-small cell lung carcinoma | KRAS is frequently mutated in non-small cell lung cancers (NSCLC), resulting in ... | BeFree | 25342139 | Detail |
0.005 | Non-small cell lung carcinoma | Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small... | BeFree | 25400829 | Detail |
0.005 | Non-small cell lung carcinoma | FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC. | BeFree | 25700356 | Detail |
0.001 | renal cell carcinoma | Downregulation of tNASP inhibits proliferation through regulating cell cycle-rel... | BeFree | 25669170 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
In summary loss of EphB2 and gain of EphB4 expression represents an inflection point in the developm... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCL12-CXCR7 signaling activates ERK and Akt pathways in human choriocarcinoma cells. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer thr... | DisGeNET | Detail |
Taken together, the present study demonstrated that BK increases IL-6 production via B2R and the ERK... | DisGeNET | Detail |
In conclusion, PXN promotes Bcl-2 phosphorylation at Serine 87 via PXN-mediated ERK activation, and ... | DisGeNET | Detail |
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycl... | DisGeNET | Detail |
Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results indicate that an MKP-3 pathway might regulate ERK dephosphorylation through Nox4 during ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Up-regulation of Bcl-2 by CD147 Through ERK Activation Results in Abnormal Cell Survival in Human En... | DisGeNET | Detail |
EphB2 activation is required for ependymoma development as well as inhibits differentiation and prom... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Application of a specific extracellular-related kinase 1/2 (ERK1/2) inhibitor, but not application o... | DisGeNET | Detail |
Here we propose that the blinding of cell-cell contact sensing in gliomas is caused by an unusual me... | DisGeNET | Detail |
Furthermore, AND did not induce apoptosis or activate ERK and p53 in primary cultured astrocyte cell... | DisGeNET | Detail |
Taken together, our findings showed that HDAC3 contributed to VM in gliomas, possibly through the PI... | DisGeNET | Detail |
Syk and ERK may serve as new therapeutic targets for interfering with ADE-induced cytokine expressio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results of BNDF research show that neurotrophins regulate miRNAs in at least three ways: (1) ERK... | DisGeNET | Detail |
These results indicate that high AR expression in the context of hyperglycemia and insulin deficienc... | DisGeNET | Detail |
Irisin treatment significantly increased insulin-like growth factor 1 and decreased myostatin gene e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We also found that blocking ET(A)R via BQ-123 interferes with ERK phosphorylation and CLL pro-surviv... | DisGeNET | Detail |
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
At the molecular level, reduced activation of ERK MAPK, but not Akt, was observed in lung tumours of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We discovered that YC-1 induces apoptosis and inhibits tumour growth of breast cancer cells via down... | DisGeNET | Detail |
Mechanistically, SHP2/ERK inhibition impedes c-Myc transcriptional activity, which results in the re... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Deactivation of phosphorylation of ERK protein is one of the mechanisms of sorafenib inhibiting gast... | DisGeNET | Detail |
These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that promotes proliferati... | DisGeNET | Detail |
WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the expression and activi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mesothelioma tumors are locally invasive and our results clearly suggest that acivins have a tumor-p... | DisGeNET | Detail |
In summary, our results suggest that quercetin suppresses the proliferation of MM cells by down-regu... | DisGeNET | Detail |
Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its downstream signaling... | DisGeNET | Detail |
The oncogene ABL1 was a direct miR-3127-5p target, and miR-3127-5p regulated the activation of the A... | DisGeNET | Detail |
In conclusion, these findings demonstrate that EMT can be regulated by the CCL19/CXCR7 axis in epith... | DisGeNET | Detail |
In conclusion, this study suggested that EMT process can be triggered by the BMP2/BMPR axis in gastr... | DisGeNET | Detail |
We also show that mice that have tumors with intrinsically high levels of active AKT and ERK are mor... | DisGeNET | Detail |
WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the expression and activi... | DisGeNET | Detail |
A cell-based assay was developed using natively expressed ORL-1 receptors on mouse neuroblastoma cel... | DisGeNET | Detail |
Mechanistically treatment of NBs with small molecule inhibitors of EGFR (erlotinib, cetuximab) and E... | DisGeNET | Detail |
Furthermore, the amount of phosphorylation of the kinase ERK and neurite outgrowth increased upon Cb... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moving beyond BRAFV600 targeting, a number of other molecular subsets--such as mutations in MEK, NRA... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Current data exclude a major function of these syntrophins in ABCA1 activity and insulin release but... | DisGeNET | Detail |
Our data suggest that H2S prevents the development of opioid withdrawal-induced hyperalgesia via sup... | DisGeNET | Detail |
To investigate the involvement of these pathways in the Naproxen-induced COL10A1 expression, we incu... | DisGeNET | Detail |
Taken together, data show CTGF elevating MMPs expression and subsequently promoting tumor metastasis... | DisGeNET | Detail |
Taken together, our data suggest that miR-143 inhibits EGFR signaling through its downstream ERK/MAP... | DisGeNET | Detail |
These regulatory effects of EC on ovarian cancer cell proliferation, migration and invasion were ass... | DisGeNET | Detail |
MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the P... | DisGeNET | Detail |
In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B and inhibit the cat... | DisGeNET | Detail |
We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is oncogenic in NIH/3T3 cel... | DisGeNET | Detail |
NA | DisGeNET | Detail |
ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: implications for Par... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We tested RDEA119, a specific MEK1/2 (MAPK extracellular signal-regulated kinase [ERK] kinase) inhib... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactivation in prostate ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, our data suggest that miR99a inhibits MMP7 and MMP13 through PI3k/Akt and ERK/MAPK s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
When expressed in rat pheochromocytoma cell line cells, the R151C, R160W and D294H MC1R variants ass... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Eighty percent of these genes were functionally associated with a key stress response signalling cas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antivi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Lupalbigenin treatment significantly down-regulated survival proteins, including protein kinase B (p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
LATS2 mRNA level was found to be a significant independent predictor for survival status (disease-fr... | DisGeNET | Detail |
Genetic alterations affecting the MAPK/ERK pathway are common in lung adenocarcinoma (LAD). | DisGeNET | Detail |
To elucidate how EGFR signaling is linked to metabolic activity, we investigated the involvement of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced anchorage-... | DisGeNET | Detail |
ARB blocked A2-induced GBC cell growth and activated ERK. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, while p53R2, a p53-inducible peptide involved in the synthesis of dNTPs normally works ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced anchorage-... | DisGeNET | Detail |
Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
ARB blocked A2-induced GBC cell growth and activated ERK. | DisGeNET | Detail |
Further analysis showed that Cyr61 seemed to activate phosphatidylinositol 3-kinase (PI3K) but not e... | DisGeNET | Detail |
ERK pathway knockdown suppressed pancreatic cancer cell proliferation, invasion, and angiogenesis. | DisGeNET | Detail |
We propose that dual PI3K/mTOR inhibitors suppress a novel negative feedback loop mediated by mTORC2... | DisGeNET | Detail |
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. | DisGeNET | Detail |
Analysis of western blotting data showed that total protein isoforms of Raf, MEK and ERK were simila... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our investigation of the molecular mechanisms underlying these effects revealed that mortalin deplet... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression of tumour suppressor genes was reduced in tumours from current versus never-smoking l... | DisGeNET | Detail |
The results indicated that Sorcin may be used as a potential therapeutic target for MDR through inhi... | DisGeNET | Detail |
Here, we reported that the AKT inhibitor perifosine and the MEK\ERK inhibitor MEK-162 synergisticall... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Guanine nucleotide binding protein alpha13 (GNA13) and protein tyrosine phosphatase type IVA (PTP4A)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genome-wide analyses have identified four major signaling nodes that are most frequently altered in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell inv... | DisGeNET | Detail |
In this article, Paul B. Chapman, MD, Memorial Sloan Kettering Cancer Center, summarizes the recent ... | DisGeNET | Detail |
Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells. | DisGeNET | Detail |
Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathway... | DisGeNET | Detail |
Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitiona... | DisGeNET | Detail |
In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B and inhibit the cat... | DisGeNET | Detail |
Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliom... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells. | DisGeNET | Detail |
Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
ERK pathway knockdown suppressed pancreatic cancer cell proliferation, invasion, and angiogenesis. | DisGeNET | Detail |
We propose that dual PI3K/mTOR inhibitors suppress a novel negative feedback loop mediated by mTORC2... | DisGeNET | Detail |
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Combined CagA expression, p-SHP-2 expression, and p-ERK expression showed an increased positive pred... | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactivation in prostate ca... | DisGeNET | Detail |
Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through ... | DisGeNET | Detail |
Finally, the results demonstrated that AQP3 upregulated matrix metalloproteinase‑3 (MMP‑3) expressio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Functional bioinformatics analysis identified as downstream targets multiple signaling pathways pote... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and prov... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and p... | DisGeNET | Detail |
EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, data show CTGF elevating MMPs expression and subsequently promoting tumor metastasis... | DisGeNET | Detail |
Taken together, our data suggest that miR-143 inhibits EGFR signaling through its downstream ERK/MAP... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactivation in prostate ca... | DisGeNET | Detail |
Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through ... | DisGeNET | Detail |
Finally, the results demonstrated that AQP3 upregulated matrix metalloproteinase‑3 (MMP‑3) expressio... | DisGeNET | Detail |
Furthermore, BAG3 knockdown increased the HT-induced phosphorylation of ERK after HT treatment, and ... | DisGeNET | Detail |
In conclusion, CrkL protein is required for TGF-β signal pathways through AKT and ERK pathway, which... | DisGeNET | Detail |
CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathways in epithelial ovar... | DisGeNET | Detail |
By far, the most common clinical resistance mechanism involves reactivation of the MAPK (RAF/MEK/ERK... | DisGeNET | Detail |
As the MAPK pathway is an important target for treating triple-negative breast cancers, upstream Nod... | DisGeNET | Detail |
Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in breast cancer cells with... | DisGeNET | Detail |
Verification of EPHB2 regulation by TGF-β3 and p53 was performed on breast cancer tumor cell lines. | DisGeNET | Detail |
Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI0... | DisGeNET | Detail |
Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK ... | DisGeNET | Detail |
The expression of tumour suppressor genes was reduced in tumours from current versus never-smoking l... | DisGeNET | Detail |
The results indicated that Sorcin may be used as a potential therapeutic target for MDR through inhi... | DisGeNET | Detail |
Here, we reported that the AKT inhibitor perifosine and the MEK\ERK inhibitor MEK-162 synergisticall... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Activation of Rac1-ERK pathway and consequent upregulation of MMP-7 production may contribute to the... | DisGeNET | Detail |
Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT... | DisGeNET | Detail |
These data suggest that EGF-induced activation of MMP7 and MMP13 in GC is through phosphatidylinosit... | DisGeNET | Detail |
Deactivation of phosphorylation of ERK protein is one of the mechanisms of sorafenib inhibiting gast... | DisGeNET | Detail |
These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that promotes proliferati... | DisGeNET | Detail |
WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the expression and activi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
A cell-based assay was developed using natively expressed ORL-1 receptors on mouse neuroblastoma cel... | DisGeNET | Detail |
Mechanistically treatment of NBs with small molecule inhibitors of EGFR (erlotinib, cetuximab) and E... | DisGeNET | Detail |
Furthermore, the amount of phosphorylation of the kinase ERK and neurite outgrowth increased upon Cb... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Tumor cell-specific overexpression of EphB2 was detected in human cSCCs and in chemically induced mo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These regulatory effects of EC on ovarian cancer cell proliferation, migration and invasion were ass... | DisGeNET | Detail |
MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the P... | DisGeNET | Detail |
In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B and inhibit the cat... | DisGeNET | Detail |
We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is oncogenic in NIH/3T3 cel... | DisGeNET | Detail |
One potential therapeutic target for HNSCC is the RAS/RAF/MEK/ERK cascade, which is one of the major... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Eighty percent of these genes were functionally associated with a key stress response signalling cas... | DisGeNET | Detail |
These results suggest that our new Braf knockin mice recapitulate major features of RASopathies and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moreover, several signal transduction pathways that are critical for the proliferation and survival ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The data suggest that ERK activation by Nodal signaling regulates c-myc and p27 proteins post-transl... | DisGeNET | Detail |
Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although it had relatively short half-life in serum, it was shown to be highly significant anti-tumo... | DisGeNET | Detail |
Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer thr... | DisGeNET | Detail |
Taken together, the present study demonstrated that BK increases IL-6 production via B2R and the ERK... | DisGeNET | Detail |
In conclusion, PXN promotes Bcl-2 phosphorylation at Serine 87 via PXN-mediated ERK activation, and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Functional bioinformatics analysis identified as downstream targets multiple signaling pathways pote... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We have also shown that metformin activates the ERK pathway in Ph+ALL cells, SUP-B15, a side effect ... | DisGeNET | Detail |
Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK sig... | DisGeNET | Detail |
The CXCR7-ERK-HNF4α cascade represents a new target for the differentiation therapy of HCC. | DisGeNET | Detail |
These results suggest that SIRT6 is required for TGF-β1/H2O2/HOCl to enhance the tumorigenicity of H... | DisGeNET | Detail |
Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development. | DisGeNET | Detail |
Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In aggressive, triple-negative, basal-like breast cancers, most tumors display increased MEK and ERK... | DisGeNET | Detail |
In the present study we discerned the molecular mechanisms of potential interaction between the endo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The small interfering RNA (siRNA) was used to suppress CrkL in serous papillary cystic adenocarcinom... | DisGeNET | Detail |
NA | DisGeNET | Detail |
This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and prov... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
(D) PGC-1β mediated NF-κB transcription in RA-FLS, but did not affect ERK and p38. | DisGeNET | Detail |
Sprouty2 suppresses the inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and br... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The naturally secreted and O-GlcNAcylated MIF binds to EGFR, thereby inhibiting the binding of EGF t... | DisGeNET | Detail |
Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in breast cancer cells with... | DisGeNET | Detail |
Verification of EPHB2 regulation by TGF-β3 and p53 was performed on breast cancer tumor cell lines. | DisGeNET | Detail |
Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI0... | DisGeNET | Detail |
Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK ... | DisGeNET | Detail |
Activation of Rac1-ERK pathway and consequent upregulation of MMP-7 production may contribute to the... | DisGeNET | Detail |
Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT... | DisGeNET | Detail |
Functional bioinformatics analysis identified as downstream targets multiple signaling pathways pote... | DisGeNET | Detail |
These findings provide mechanistic evidence for the role of EphB2 in the early progression of cSCC t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib se... | DisGeNET | Detail |
KRAS is frequently mutated in non-small cell lung cancers (NSCLC), resulting in activation of the ME... | DisGeNET | Detail |
Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer ce... | DisGeNET | Detail |
FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC. | DisGeNET | Detail |
Downregulation of tNASP inhibits proliferation through regulating cell cycle-related proteins and in... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386505388 dbSNP
- Genome
- hg38
- Position
- chr1:22,710,839-22,921,500
- Variant Type
- snv
Genome browser